首頁 > 市場調查報告書 > 食物/飲料

食品添加劑

市場調查報告書

商品編碼

1297801

全球生物技術原料市場 - 2023-2030年

Global Biotech ingredients Market - 2023-2030

出版日期: 2023年06月15日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球生物技術原料市場在2022年達到566億美元，預計到2030年將見證有利可圖的成長，達到860億美元。在預測期內（2023-2030年），全球生物技術原料市場預計將呈現5.5%的複合成長率。

近年來，由於各種趨勢，如對天然和有機產品的需求上升，藥物開發和治療的進步，在個人護理和化妝品中的應用不斷增加，農業生物技術的擴展，以及對永續性和環境影響的關注，全球生物技術配料市場已大幅成長。

全球生物技術原料市場受到多種因素的驅動，如生物技術的進步、各行業採用的增加、個人護理和化妝品需求的增加以及消費者對永續和天然產品需求的增加。例如，基因工程、合成生物學和生物加工等方面的進步，大大拓寬了生物技術物質的範圍。

市場動態

個人護理和化妝品需求的增加推動了全球生物技術原料市場的成長

天然和有機產品在個人護理和化妝品領域的需求量很大，在其中使用生物技術成分將推動全球生物技術成分市場的發展。消費者越來越注意他們在皮膚和頭髮上使用的產品，他們正在尋找典型化妝品配方的天然和有機替代品。生物技術衍生的酶，如蛋白酶和脂肪酶，具有獨特的品質，使它們適合用於護膚品。

例如，2022年4月，瑞典的一家生物技術企業Probi與全球配料供應商Symrise合作，為化妝品護膚品開發一種獨特的後生物製劑。這種合作關係導致了SymFerment的誕生，這是一種非凡的回收成分，以Symrise品牌銷售。

SymFerment是由乳酸菌發酵物創造的，這是一種從植物乳桿菌的發酵過程中獲得的永續副產品。由此產生的發酵液，也被稱為上清液，具有適用於護膚品應用的特殊特性。它含有大量支持皮膚健康的微量營養素，如氨基酸、蛋白質、礦物質和有機酸。

食品和飲料行業越來越多的採用，推動了全球生物技術配料市場的成長。

食品和飲料行業擴大採用生物技術配料是由幾個因素驅動的，包括需要提高食品品質、延長保存期限和改善營養狀況。消費者擴大尋找清潔標籤和天然食品，這增加了對該領域生物技術成分的需求。

例如，2023年3月，位於加利福尼亞州的生物技術初創公司Shiru推出了其第一個市場產品OleoPro。這種新穎的產品是一種植物蛋白衍生的脂肪，旨在用於替代肉和其他基於植物的烹飪應用。 Shiru公司開創性的Flourish技術平台產生了OleoPro，這是一種卓越的替代脂肪成分，結合了永續性、高性能和營養價值。

技術和製造方面的挑戰阻礙了市場的發展

生物技術配料的生產通常需要專門的基礎設施、設備和經驗，而這些可能並不常見或不容易獲得。這些問題會對生產過程的可擴展性和成本效益產生影響。建立和維護專門的設施，如生物反應器、發酵罐或潔淨室，可能是昂貴和費時的。

隨著對生物技術部件需求的發展，擴大生產程序正變得越來越重要，但這可能是困難的。隨著生產數量的擴大，保持穩定的產品品質、最佳化產量和保證可重複性變得更加困難。原料、加工條件和生物系統的變化都會對產品的一致性產生影響，因此需要嚴格的品質控製程序。因此，由於上述因素，預計市場將在預測期內受到阻礙。

COVID-19影響分析

COVID-19大流行病對全球生物技術原料市場產生了巨大影響。對生物製藥如疫苗和單克隆抗體的需求上升，提高了對用於配方的生物技術成分的需求。然而，供應鏈問題影響了成分的可用性。政府和組織集中精力提高疫苗製造能力，從而增加了需求。

監管的靈活性和快速審批促進了生物技術物質的及時供應。這場大流行引發了研究和開發計劃，強調了持續創新和投資生物技術元素的重要性，以解決新的健康問題。 COVID-19對全球生物技術成分市場的長期影響仍在確定之中。

俄羅斯-烏克蘭衝突分析

俄烏衝突有可能擾亂全球生物技術成分的供應鏈，特別是在受影響的國家。這可能會導致世界各地的生物技術原料的延遲或短缺。地緣政治的不確定性可能對生物技術行業的投資決策和公司營運產生影響，可能改變全球供應鏈。與戰爭有關的監管措施可能對貿易產生影響，並提高合規成本。

此外，市場信心和投資者情緒可能受到損害，從而損害生物技術行業的資金和投資。俄羅斯和烏克蘭的區域生物技術成分市場可能會在業務連續性和進入國際市場方面遇到問題。持續的監測和靈活性對於利益相關者駕馭衝突對全球生物技術成分市場的影響至關重要。

Market Overview

The Global Biotech Ingredients Market reached US$ 56.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 86.0 billion by 2030. The global biotech ingredients market is expected to exhibit a CAGR of 5.5% during the forecast period (2023-2030).

The global biotech ingredients market has grown significantly in recent years, due to various trends such as rising demand for natural and organic products, advancements in drug development and therapies, growing application in personal care and cosmetics, expansion in agricultural biotechnology, and focus on sustainability and environmental impact.

The global biotech ingredients market is driven by multiple factors such as the advancements in biotechnology, increasing adoption across industries, increasing demand for personal care and cosmetics, and growing consumer demand for sustainable and natural products. For instance, the advancements such as genetic engineering, synthetic biology, and bioprocessing have considerably broadened the scope of biotech substances.

Market Dynamics

The Increasing Demand for Personal Care and Cosmetics is Propelling the Growth of the Global Biotech Ingredients Market

Natural and organic products are in high demand in the personal care and cosmetics sector, use of biotech ingredients in it will drive the global biotech ingredients market. Consumers are becoming more aware of the products they use on their skin and hair, and they are looking for natural and organic alternatives to typical cosmetic formulas. Biotechnology-derived enzymes, such as proteases and lipases, have unique qualities that make them appropriate for skincare products.

For instance, in April 2022, Probi, a Swedish biotech business, collaborated with Symrise, a global ingredient supplier, to develop a unique postbiotic for cosmetic skincare. This partnership resulted in the creation of SymFerment, an extraordinary recycled ingredient marketed under the Symrise brand.

SymFerment is created from Lactobacillus Ferment, a sustainable byproduct obtained from the fermentation process of the bacteria Lactiplantibacillus plantarum. The fermentation broth that results, also known as the supernatant, has exceptional properties that are suitable for skincare applications. It is high in micronutrients that support skin health, such as amino acids, proteins, minerals, and organic acids.

The Growing Adoption in Food and Beverage Industry is Driving the Growth of the Global Biotech ingredients Market

The growing adoption of biotech ingredients in the food and beverage industry is driven by several factors, including the need to enhance food quality, extend shelf life, and improve nutritional profiles. Consumers are increasingly looking for clean-label and natural food items, which has increased demand for biotech components in this area.

For instance, in March 2023, Shiru, a biotech startup based in California, launched its first market offering, OleoPro. This novel product is a plant protein-derived fat intended for substitute meat and other plant-based culinary applications. Shiru's pioneering Flourish technology platform yielded OleoPro, a superior alternative fat ingredient that combines sustainability, high performance, and nutritional value.

The Technical and Manufacturing Challenges is Hampering the Growth of the Market

Biotech ingredient production often requires specialized infrastructure, equipment, and experience that may not be commonly available or easily accessible. These issues can have an impact on the scalability and cost-effectiveness of manufacturing processes. Establishing and maintaining specialized facilities such as bioreactors, fermentation tanks, or cleanrooms can be costly and time-consuming.

Scaling up production procedures is becoming increasingly important as demand for biotech components develops, but it can be difficult. As production numbers expand, maintaining consistent product quality, optimizing yields, and assuring reproducibility become more difficult. Variations in raw materials, processing conditions, and biological systems can all have an impact on product consistency, necessitating stringent quality control procedures. Thus, owing to the above factors, the market is expected to hamper over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic had a huge impact on the global biotech ingredients market. The rising demand for biopharmaceuticals such as vaccines and monoclonal antibodies raised the demand for biotech components used in the formulation. However, supply chain problems impacted ingredient availability. Governments and organizations concentrated on increasing vaccine manufacturing capacity, which increased demand.

Regulatory flexibility and quick approvals facilitated the timely availability of biotech substances. The pandemic sparked research and development initiatives, emphasizing the significance of continual innovation and investment in biotech elements to address new health concerns. The long-term impacts of COVID-19 on the global biotech ingredients market are still being determined.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict has the potential to disrupt global biotech ingredient supply chains, particularly in affected countries. This might cause biotech ingredient delays or shortages around the world. Geopolitical uncertainty may have an impact on investment decisions and company operations in the biotech industry, potentially changing the global supply chain. Regulatory measures relating to the war may have an impact on trade and raise compliance costs.

Moreover, market confidence and investor sentiment may be harmed, thereby hurting funding and investment in the biotech sector. Regional biotech ingredient markets in Russia and Ukraine may encounter problems in terms of business continuity and access to international markets. Continuous monitoring and flexibility are critical for stakeholders navigating the conflict's influence on the global biotech ingredients market.

Segment Analysis

The global biotech ingredients market is segmented based on type, product, expression system, end user, and region.

The Mammalian Expression System Segment is expected to hold a Dominant Position in the Global Biotech Ingredients Market over the Forecast Period.

The mammalian expression system segment is expected to hold 35.9% of market share for the global biotech ingredients market. Owing to the factors such as optimal protein functionality, complex biotech ingredient production, and downstream processing efficiency. Mammalian expression systems, which use mammalian cells, have distinct benefits for producing complex biotech ingredients, particularly therapeutic proteins and antibodies.

Moreover, many collaboration are ongoing for utilization of this mammalian expression system. For instance, in April 2022, Luzhu Biotech and Lonza, a global development and manufacturing partner to the pharmaceutical, biotech, and nutritional industries, have entered into a research and commercial license agreement for Luzhu to use Lonza's GS Xceed Gene Expression System with GS piggyBac transposon technology. Luzhu Biotech is a biopharmaceutical business dedicated to the discovery and development of novel therapeutic candidates for the prevention, control, and treatment of human diseases.

Geographical Analysis

North America Holds a Dominant Position in the Global Biotech Ingredients Market

North America is estimated to hold around 37.8% of the total market share throughout the forecast period, owing to the well-established healthcare infrastructure, favorable reimbursement policies, and presence of leading market players.

The United States is an example of North America's dominance. The country is a center for many biotech ingredient manufacturers as well as prominent research organizations. The headquarters of notable biotech businesses such as Amgen, Genentech, and Biogen are in the United States. These firms have played critical roles in the development and production of biotech ingredients, contributing to the market growth in North America.

Furthermore, renowned research institutions like as Massachusetts Institute of Technology (MIT) and University of California, San Francisco (UCSF) conduct pioneering research, driving innovation and bolstering North America's dominance in the global biotech ingredients market. Therefore, North America dominates the global biotech ingredients market with key companies, research infrastructure, and innovation focus.

Competitive Landscape

The major global players in the market include: Mylan, Inc., Pfizer, Inc., Novartis AG, Sigma-Aldrich (Merck KGaA), Bristol-Myers Squibb Company, Sanofi, Teva, AstraZeneca, BD, and AbbVie Inc., among others.

Why Purchase the Report?

To visualize the global biotech ingredients market segmentation based on the coating, end user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global biotech ingredients market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global biotech ingredients market report would provide approximately 49 tables, 53 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Product
3.3. Snippet by Expression System
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand for Biotech Flavors and Fragrance Ingredients
  - 4.1.1.2. Growing Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Limited Availability of Raw Materials 0wing to the Requirement of Ambient Conditions
- 4.1.3. Opportunity
  - 4.1.3.1. Increasing Demand for Nutraceuticals
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2. Market Attractiveness Index, By Type
8.2. Innovative Biotech APIs*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Generic Biotech APIs/Biosimilar

9. By Product

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.1.2. Market Attractiveness Index, By Product
9.2. Monoclonal Antibodies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Vaccines
9.4. Cytokines
9.5. Fusion Proteins
9.6. Therapeutic Enzymes
9.7. Hormones and Growth Factors
9.8. Blood Factors
9.9. Others

10. By Expression System

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
- 10.1.2. Market Attractiveness Index, By Expression System
10.2. Microbial*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Mammalian
10.4. Plant
10.5. Yeast
10.6. Insect
10.7. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.6.1. The U.S.
  - 11.2.6.2. Canada
  - 11.2.6.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.6.1. Germany
  - 11.3.6.2. The U.K.
  - 11.3.6.3. France
  - 11.3.6.4. Italy
  - 11.3.6.5. Spain
  - 11.3.6.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.6.1. Brazil
  - 11.4.6.2. Argentina
  - 11.4.6.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.6.1. China
  - 11.5.6.2. India
  - 11.5.6.3. Japan
  - 11.5.6.4. Australia
  - 11.5.6.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Product Benchmarking
12.3. Company Share Analysis
12.4. Key Developments and Strategies

13. Company Profiles

13.1. Mylan, Inc.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Pfizer, Inc.
13.3. Novartis AG
13.4. Sigma-Aldrich (Merck KGaA)
13.5. Bristol-Myers Squibb Company
13.6. Sanofi
13.7. Teva
13.8. AstraZeneca
13.9. BD
13.10. AbbVie Inc.

LIST NOT EXHAUSTIVE